The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Therapeutic cancer targeting peptides
Abstract
Antitumor monoclonal antibodies have shown clinical promise as cancer cell surface targeting agents. More tumor targeting antibodies are likely to be approved by the FDA in the next few years. However, there are two major limitations in antibody‐targeted therapy: large size and nonspecific uptake of the antibody molecules by the liver and the reticuloendothelial system. These result in poor tumor penetration of antibody pharmaceuticals and dose‐limiting toxicity to the liver and bone marrow. Peptides are excellent alternative targeting agents for human cancers, and they may alleviate some of the problems with antibody targeting. In the last decade, several investigators have successfully used combinatorial library methods to discover cell surface binding peptides that may be useful for cancer targeting. The phage‐display library technique and the “one‐bead one‐compound” combinatorial library method are the two approaches that have been used. Cancer cell surface receptors or endothelial cell surface receptors of the neovasculature are the two popular therapeutic targets for cancer. Results from preclinical studies with some peptides are encouraging in their targeting potential. © 2002 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 66: 184–199, 2002
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Light-Directed, Spatially Addressable Parallel Chemical Synthesis
Fodor, S. P. A., Read, J. L., Pirrung, M. C., Stryer, L., Lu, A. T., & Solas, D. (1991) · Science · doi:10.1126/science.1990438 · Cited by 2,696
Searching for Peptide Ligands with an Epitope Library
Scott, J. K., & Smith, G. P. (1990) · Science · doi:10.1126/science.1696028 · Cited by 2,084
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
Arap, W., Pasqualini, R., & Ruoslahti, E. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,054
A new type of synthetic peptide library for identifying ligand-binding activity
Lam, K. S., Salmon, S. E., Hersh, E. M., Hruby, V. J., Kazmierski, W. M., & Knapp, R. J. (1991) · Nature · doi:10.1038/354082a0 · Cited by 1,802
Self-citationAntiangiogenic therapy of experimental cancer does not induce acquired drug resistance
Boehm, T., Folkman, J., Browder, T., & O'Reilly, M. S. (1997) · Nature · doi:10.1038/37126 · Cited by 1,683
Geysen, H. M., Meloen, R. H., & Barteling, S. J. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.13.3998 · Cited by 1,475
SISSAOUI, M. (2018) · Archives of Clinical Microbiology · doi:10.4172/1989-8436-c3-011 · Cited by 1,349
Houghten, R. A., Pinilla, C., Blondelle, S. E., Appel, J. R., Dooley, C. T., & Cuervo, J. H. (1991) · Nature · doi:10.1038/354084a0 · Cited by 1,326
General method for rapid synthesis of multicomponent peptide mixtures
FURKA, Á., SEBESTYÉN, F., ASGEDOM, M., & DIBÓ, G. (1991) · International Journal of Peptide and Protein Research · doi:10.1111/j.1399-3011.1991.tb00765.x · Cited by 1,155
Frank, R. (1992) · Tetrahedron · doi:10.1016/s0040-4020(01)85612-x · Cited by 1,064
Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype Antibody
Miller, R. A., Maloney, D. G., Warnke, R., & Levy, R. (1982) · New England Journal of Medicine · doi:10.1056/nejm198203043060906 · Cited by 985
Anti-cancer activity of targeted pro-apoptotic peptides
Ellerby, H. M., Arap, W., Ellerby, L. M., Kain, R., Andrusiak, R., Rio, G. D., Krajewski, S., Lombardo, C. R., Rao, R., Ruoslahti, E., et al. (1999) · Nature Medicine · doi:10.1038/12469 · Cited by 936
Peptides on phage: a vast library of peptides for identifying ligands.
Cwirla, S. E., Peters, E. A., Barrett, R. W., & Dower, W. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.16.6378 · Cited by 928
Random Peptide Libraries: a Source of Specific Protein Binding Molecules
Devlin, J. J., Panganiban, L. C., & Devlin, P. E. (1990) · Science · doi:10.1126/science.2143033 · Cited by 922
Coiffier, B., Haïoun, C., Ketterer, N., Engert, A., Tilly, H., Ma, D. D. F., Johnson, P., Lister, A., Feuring‐Buske, M., Radford, J. A., et al. (1998) · PubMed · doi:10.1182/blood.v92.6.1927 · Cited by 893
Antibody-selectable filamentous fd phage vectors: affinity purification of target genes
Parmley, S. F., & Smith, G. P. (1988) · Gene · doi:10.1016/0378-1119(88)90495-7 · Cited by 867
Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.
Pasqualini, R., Koivunen, E., Kain, R., Lahdenranta, J., Sakamoto, M., Stryhn, A., Ashmun, R., Shapiro, L., Arap, W., & Ruoslahti, E. I. (2000) · PubMed · Cited by 859
αv Integrins as receptors for tumor targeting by circulating ligands
Pasqualini, R., Koivunen, E., & Ruoslahti, E. (1997) · Nature Biotechnology · doi:10.1038/nbt0697-542 · Cited by 744
Maskless fabrication of light-directed oligonucleotide microarrays using a digital micromirror array
Singh-Gasson, S., Green, R. D., Yue, Y., Nelson, C., Blattner, F., Sussman, M. R., & Cerrina, F. (1999) · Nature Biotechnology · doi:10.1038/13664 · Cited by 733
The “One-Bead-One-Compound” Combinatorial Library Method
Lam, K. S., Lebl, M., & Krchňák, V. (1997) · Chemical Reviews · doi:10.1021/cr9600114 · Cited by 713
Self-citationRadiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow Support
Press, O. W., Eary, J. F., Appelbaum, F. R., Martin, P. J., Badger, C. C., Nelp, W. B., Glenn, S., Butchko, G., Fisher, D., Porter, B., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310213291702 · Cited by 644
Steps toward mapping the human vasculature by phage display
Arap, W., Kolonin, M. G., Trepel, M., Lahdenranta, J., Cardó-Vila, M., Giordano, R. J., Mintz, P. J., Ardelt, P. U., Yao, V. J., Vidal, C. I., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-121 · Cited by 607
Tumor targeting with a selective gelatinase inhibitor
Koivunen, E., Arap, W., Valtanen, H., Rainisalo, A., Medina, O. P., Heikkilä, P., Kantor, C., Gahmberg, C. G., Salo, T., Konttinen, Y. T., et al. (1999) · Nature Biotechnology · doi:10.1038/11703 · Cited by 567
Radioimmunotherapy of B-Cell Lymphoma with [131I]Anti-B1 (Anti-CD20) Antibody
Kaminski, M. S., Zasadny, K. R., Francis, I. R., Milik, A. W., Ross, C. W., Moon, S. D., Crawford, S. M., Burgess, J. M., Petry, N. A., Butchko, G. M., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308123290703 · Cited by 547
An in vitro polysome display system for identifying ligands from very large peptide libraries.
Mattheakis, L. C., Bhatt, R. R., & Dower, W. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9022 · Cited by 514
Koivunen, E., Wang, B., & Ruoslahti, E. (1995) · Nature Biotechnology · doi:10.1038/nbt0395-265 · Cited by 477
Press, O. W., Appelbaum, F., Martin, P. J., Matthews, D. C., Bernstein, I. D., Eary, J. F., Nelp, W. B., Gooley, T., Glenn, S., Porter, B., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92225-3 · Cited by 428
Curnis, F., Sacchi, A., Borgna, L., Magni, F., Gasparri, A., & Corti, A. (2000) · Nature Biotechnology · doi:10.1038/81183 · Cited by 419
A clinical trial of anti-idiotype therapy for B cell malignancy
Meeker, T., Lowder, J., Maloney, D., Miller, R., Thielemans, K., Warnke, R., & Levy, R. (1985) · Blood · doi:10.1182/blood.v65.6.1349.bloodjournal6561349 · Cited by 416
Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma
Kaminski, M. S., Zasadny, K. R., Francis, I. R., Fenner, M. C., Ross, C. W., Milik, A. W., Estes, J., Tuck, M., Regan, D., Fisher, S., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.7.1974 · Cited by 396
Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis
Binetruy-Tournaire, R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.7.1525 · Cited by 295
Design, Synthesis, and Evaluation of Small-Molecule Libraries
Ellman, J. A. (1996) · Accounts of Chemical Research · doi:10.1021/ar950190w · Cited by 289
Liu, S. Y., Eary, J. F., Petersdorf, S. H., Martin, P. J., Maloney, D. G., Appelbaum, F. R., Matthews, D. C., Bush, S. A., Durack, L. D., Fisher, D. R., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3270 · Cited by 286
Targeting the prostate for destruction through a vascular address
Arap, W., Haedicke, W., Bernasconi, M., Kain, R., Rajotte, D., Krajewski, S., Ellerby, H. M., Bredesen, D. E., Pasqualini, R., & Ruoslahti, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241655998 · Cited by 285
Curnis, F., Arrigoni, G., Sacchi, A., Fischetti, L., Arap, W., Pasqualini, R., & Corti, A. (2002) · PubMed · Cited by 279
Biopanning and rapid analysis of selective interactive ligands
Giordano, R. J., Cardó‐Vila, M., Lahdenranta, J., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1249 · Cited by 276
Delivery of molecular and cellular medicine to solid tumors
Jain, R. K. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00027-6 · Cited by 271
Epidermal growth factor receptor biology (IMC-C225)
Kim, E. S., Khuri, F. R., & Herbst, R. S. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200111000-00014 · Cited by 242
Incorporation of Tumor-Targeting Peptides into Recombinant Adeno-associated Virus Capsids
Grifman, M., Trepel, M., Speece, P., Gilbert, L. B., Arap, W., Pasqualini, R., & Weitzman, M. D. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0345 · Cited by 241
Dvorak, H. F., Nagy, J. A., & Dvořàk, A. M. (1991) · PubMed · Cited by 203
Delivery of Molecular and Cellular Medicine to Solid Tumors
Jain, R. K. (1997) · Microcirculation · doi:10.3109/10739689709148314 · Cited by 198
Essler, M., & Ruoslahti, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251687998 · Cited by 193
In vivo phage display and vascular heterogeneity: implications for targeted medicine
Trepel, M., Arap, W., & Pasqualini, R. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00336-8 · Cited by 190
The Phosphotyrosine Interaction Domain of SHC Recognizes Tyrosine-phosphorylated NPXY Motif
Songyang, Z., Margolis, B., Chaudhuri, M., Shoelson, S. E., & Cantley, L. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.14863 · Cited by 173
NG2 proteoglycan-binding peptides target tumor neovasculature.
Burg, M. A., Pasqualini, R., Arap, W., Ruoslahti, E. I., & Stallcup, W. B. (1999) · PubMed · Cited by 166
Targeting tumor vasculature with homing peptides from phage display
Ruoslahti, E. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0334 · Cited by 157
Solution Structures and Integrin Binding Activities of an RGD Peptide with Two Isomers
Assa‐Munt, N., Jia, X., Laakkonen, P. M., & Ruoslahti, E. I. (2001) · Biochemistry · doi:10.1021/bi002101f · Cited by 157
Generating improved single-chain Fv molecules for tumor targeting
Adams, G. P., & Schier, R. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00161-1 · Cited by 146
Fukuda, M., Οhyama, C., Lowitz, K., Matsuo, O., Pasqualini, R., Ruoslahti, E. I., & Fukuda, M. (2000) · PubMed · Cited by 144
Identification of receptor ligands with phage display peptide libraries.
Koivunen, E., Arap, W., Rajotte, D., Lahdenranta, J., & Pasqualini, R. (1999) · PubMed · Cited by 137
Vascular targeting—a new approach to the therapy of solid tumors
Burrows, F. J., & Thorpe, P. E. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90037-x · Cited by 131
Neuroblastoma tumor cell-binding peptides identified through random peptide phage display
Zhang, J., Spring, H., & Schwab, M. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00575-4 · Cited by 118
Anti-neovascular therapy using novel peptides homing to angiogenic vessels
Oku, N., Asai, T., Watanabe, K., Kuromi, K., Nagatsuka, M., Kurohane, K., Kikkawa, H., Ogino, K., Tanaka, M., Ishikawa, D., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205347 · Cited by 116
Treatment of B cell malignancies with131I LYM-1 monoclonal antibodies
DeNardo, S. J., DeNardo, G. L., O'Grady, L. F., Hu, E. H.-L., Sytsma, V. M., Mills, S. L., Levy, N. B., Macey, D. J., Miller, C. H., & Epstein, A. L. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910410819 · Cited by 114
Chemotherapy targeted to tumor vasculature
Arap, W., Pasqualini, R., & Ruoslahti, E. (1998) · Current Opinion in Oncology · doi:10.1097/00001622-199811000-00014 · Cited by 108
Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature
Gerlag, D. M., Borges, E., Tak, P. P., Ellerby, H. M., Bredesen, D. E., Pasqualini, R., Ruoslahti, E. I., & Firestein, G. S. (2001) · Arthritis Research & Therapy · doi:10.1186/ar327 · Cited by 106
Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion
Romanov, V., Durand, D. B., & Petrenko, V. A. (2001) · The Prostate · doi:10.1002/pros.1068 · Cited by 96
Treatment of a Patient with b Cell Lymphoma by 1-131 Lym-1 Monoclonal Antibodies
DeNardo, S. J., DeNardo, G. L., O'Grady, L. F., Macey, D. J., Mills, S. L., Epstein, A. L., Peng, J.-S., & McGahan, J. P. (1987) · The International Journal of Biological Markers · doi:10.1177/172460088700200107 · Cited by 87
Targeted delivery of multivalent phage display vectors into mammalian cells
Ivanenkov, V. V., Felici, F., & Menon, A. G. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(98)00163-3 · Cited by 86
The use of a combinatorial library method to isolate human tumor cell adhesion peptides
Pennington, M. E., Lam, K. S., & Cress, A. E. (1996) · Molecular Diversity · doi:10.1007/bf01718696 · Cited by 70
Self-citationLeProust, E. M., Pellois, J., Yu, P., Zhang, H., Gao, X., Srivannavit, O., Gülari, E., & Zhou, X. (2000) · Journal of Combinatorial Chemistry · doi:10.1021/cc000009x · Cited by 70
Bae, D., Gho, Y. S., Yoon, W., & Chae, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13588 · Cited by 67
DeNardo, S. J., Richman, C. M., Ds, G., Shen, S., Salako, Q. A., Kukis, D. L., Meares, C. F., Yuan, A., Jl, W., & DeNardo, G. L. (1997) · PubMed · Cited by 61
Synthetic peptides inhibit adhesion of human tumor cells to extracellular matrix proteins.
DeRoock, I. B., Pennington, M. E., Sroka, T. C., Lam, K. S., Bowden, G. T., Bair, E. L., & Cress, A. E. (2001) · PubMed · Cited by 60
Self-citationPenetration of Tumor Tissue by Antibodies and Other Immunoproteins
Shockley, T. R., LIN, K., Nagy, J. A., Tompkins, R. G., Dvorak, H. F., & Yarmush, M. L. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb27257.x · Cited by 54
Brown, C. K., Modzelewski, R. A., Johnson, C. S., & Wong, M. K. K. (2000) · Annals of Surgical Oncology · doi:10.1007/s10434-000-0743-0 · Cited by 52
Renschler, M. F., Bhatt, R. R., Dower, W. J., et al. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3623 · Cited by 52
Cooke, S. P., Boxer, G., Lawrence, L., Pedley, R. B., Spencer, D. I. R., Beǵent, R. H. J., & Chester, K. A. (2001) · PubMed · Cited by 52
In vivo selection of sFv from phage display libraries
Johns, M. S., George, A. J. T., & Ritter, M. A. (2000) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00152-6 · Cited by 49
Liu, L., Liu, L., Anderson, W. F., Beart, R. W., Gordon, E. M., & Hall, F. L. (2000) · Journal of Virology · doi:10.1128/.74.11.5320-5328.2000 · Cited by 47
Laskov, R., Simon, E., & Gross, J. (1968) · International Journal of Cancer · doi:10.1002/ijc.2910030112 · Cited by 46
Radioimmunotherapy of Lymphoma: A UC Davis Experience
Lewis, J. P., DeNardo, G. L., & DeNardo, S. J. (1995) · Hybridoma · doi:10.1089/hyb.1995.14.115 · Cited by 35
Suppression of tumor growth by novel peptides homing to tumor‐derived new blood vessels
Asai, T., Nagatsuka, M., Kuromi, K., Yamakawa, S., Kurohane, K., Ogino, K., Tanaka, M., Taki, T., & Oku, N. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03265-3 · Cited by 33
TARGETED THERAPY FOR LYMPHOMA WITH PEPTIDES
Lam, K. S., & Zhao, Z. (1997) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70476-7 · Cited by 16
Self-citationImmunotherapy for non-Hodgkin's lymphoma.
Vose, J. M. (2001) · PubMed · Cited by 10
Hall, B. L., Boroughs, J., & Kobrin, B. J. (1998) · Immunotechnology · doi:10.1016/s1380-2933(98)00016-5 · Cited by 8
Cited by
Activatable Photosensitizers for Imaging and Therapy
Lovell, J. F., Liu, T. W. B., Chen, J., & Zheng, G. (2010) · Chemical Reviews · doi:10.1021/cr900236h · Cited by 1,717
Cancer Treatment Using Peptides: Current Therapies and Future Prospects
Thundimadathil, J. (2012) · Journal of Amino Acids · doi:10.1155/2012/967347 · Cited by 491
Cell-penetrating and cell-targeting peptides in drug delivery
Vivès, E., Schmidt, J., & Pèlegrin, A. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.03.001 · Cited by 441
Point-of-care biosensor systems for cancer diagnostics/prognostics
Soper, S. A., Brown, K., Ellington, A., Frazier, B., Garcia-Manero, G., Gau, V., Gutman, S. I., Hayes, D. F., Korte, B., Landers, J. L., et al. (2006) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2006.01.006 · Cited by 376
Strategies for reversing drug resistance
Fojo, T., & Bates, S. (2003) · Oncogene · doi:10.1038/sj.onc.1206951 · Cited by 357
Metadata
- Authors
- Aina, O. H., Sroka, T. C., Chen, M., & Lam, K. S.
- Venue
- Peptide Science
- Publisher
- Wiley
- Published
- 2002-01
- Volume
- 66
- Issue
- 3
- Pages
- 184-199
- ISSN
- 0006-3525 (ISSN-L)
- OpenAlex
- W2133605826
- Cited by
- 308
- References
- 78
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.